Showing results (681-690 of 3,789) with videos related to

Sort By:
Pageof 379
Oncoimmunology|August 16, 2019
Vaccinia-based oncolytic immunotherapy Pexastimogene Devacirepvec in patients with advanced hepatocellular carcinoma after sorafenib failure: a randomized multicenter Phase IIb trial (TRAVERSE)M Moehler, J Heo, H C Lee, et al.
Oncoimmunology|October 26, 2018
Updated clinical and biological information from the two-stage phase II study of imatinib mesylate in subjects with relapsed/refractory neuroblastomaFabio Morandi, Loredana Amoroso, Alessandra Dondero, et al.
Oncoimmunology|November 3, 2018
CD40L coding oncolytic adenovirus allows long-term survival of humanized mice receiving dendritic cell therapySadia Zafar, Suvi Sorsa, Mikko Siurala, et al.
Oncoimmunology|November 6, 2018
Cytokine Induced Killer cells are effective against sarcoma cancer stem cells spared by chemotherapy and target therapyGiulia Mesiano, Giovanni Grignani, Erika Fiorino, et al.
Oncoimmunology|November 6, 2018
Antagonist of cIAP1/2 and XIAP enhances anti-tumor immunity when combined with radiation and PD-1 blockade in a syngeneic model of head and neck cancerRoy Xiao, Clint T Allen, Linda Tran, et al.
Oncoimmunology|November 6, 2018
Tumor stroma-infiltrating mast cells predict prognosis and adjuvant chemotherapeutic benefits in patients with muscle invasive bladder cancerZheng Liu, Yu Zhu, Le Xu, et al.
Oncoimmunology|November 1, 2018
Predicting T cell recognition of MHC class I restricted neoepitopesZeynep Koşaloğlu-Yalçın, Manasa Lanka, Angela Frentzen, et al.
Oncoimmunology|November 1, 2018
TIM-3 expression in breast cancerSamantha Burugu, Dongxia Gao, Samuel Leung, et al.
Oncoimmunology|November 1, 2018
Human mast cells promote colon cancer growth via bidirectional crosstalk: studies in 2D and 3D coculture modelsYingxin Yu, Bart Blokhuis, Yvonne Derks, et al.
Oncoimmunology|November 1, 2018
Use of broad-spectrum antibiotics impacts outcome in patients treated with immune checkpoint inhibitorsJibran Ahmed, Arun Kumar, Kaushal Parikh, et al.
Pageof 379